Epidemiological study to describe Non-small-cell lung carcinoma (NSCLC) clinical management patterns in MENA. Lung-EPICLIN/ KSA - EPICLIN

Study identifier:NIS-MENA-SA-IRS-2010/01

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

Epidemiological study to describe NSCLC clinical management patterns in MENA. Lung-EPICLIN/ KSA

Medical condition

NSCLC patient characteristics

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

54

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Apr 2011
Estimated Primary Completion Date: 01 Mar 2013
Estimated Study Completion Date: 01 Mar 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2012 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria